AI for Drug Discovery

Using artificial intelligence to help accelerate drug discovery, screening, development, and related pharmaceutical research.

LUX TAKE:

After many years of development and interest, major pharmaceutical companies are making more significant investments in AI and forging more and deeper relationships with startups. The innovations coming out of these processes are being augmented and finding their way into the innovation processes of other physical industries.

Data last updated on April 02, 2020

What's New

Lux Research analysts and the Lux Intelligence Engine have added the following recent ai for drug discovery developments.

News Commentaries

AI for drug discovery company BenevolentAI cuts $2 billion valuation in half in recent funding round (September 25, 2019)

IBM points out chemical simulation applications for near-term quantum computing (September 11, 2019)

New Lux Content

Alternative Manufacturing Methods: Flipping Paradigms to Reach New Goals (March 31, 2020)

Pending AI (March 31, 2020)

New Patents

Computing...

New Investment Rounds

Computing...

Related companies	Schrödinger, Deep Genomics, InsideDNA, ResultCare, Cloud Pharmaceuticals, Numerate, Atomwise, Nimbus Therapeutics, Deep 6 AI, Desktop Genetics, Recursion Pharmaceuticals , Berg, Insilico Medicine, XtalPi, NuMedii, OWKIN, twoXAR, Cyclica, BioXcel Therapeutics, Verge Genomics, Exscientia, Globavir Biosciences, Engine Biosciences, Healx, Lantern Pharma, Standigm, Bioage Labs, e-Therapeutics, GTN, Mind the Byte, Quantitative Medicine, Linguamatics, BenevolentAI, Cyrus Biotechnology, Zymol

Related companies

Schrödinger, Deep Genomics, InsideDNA, ResultCare, Cloud Pharmaceuticals, Numerate, Atomwise, Nimbus Therapeutics, Deep 6 AI, Desktop Genetics, Recursion Pharmaceuticals , Berg, Insilico Medicine, XtalPi, NuMedii, OWKIN, twoXAR, Cyclica, BioXcel Therapeutics, Verge Genomics, Exscientia, Globavir Biosciences, Engine Biosciences, Healx, Lantern Pharma, Standigm, Bioage Labs, e-Therapeutics, GTN, Mind the Byte, Quantitative Medicine, Linguamatics, BenevolentAI, Cyrus Biotechnology, Zymol

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978